Jane Street
SRRA

Jane Street’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Jane Street’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-75,773
Closed -$4.17M – 10977
2022
Q2 		$4.17M Buy
75,773
+42,642
+129% +$2.24M ﹤0.01% 2944
2022
Q1 		$1.06M Buy
+33,131
New +$951K ﹤0.01% 6012

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Jane Street's SRRA Position: Q3 2022 in Review

Jane Street sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 75,773 shares — an estimated $4.17M sold.

Jane Street first reported a position in SRRA in Q1 2022 and held it in 2 quarters. The position peaked at $4.17M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Jane Street reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Jane Street sold 75,773 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $4.17M.
  • Jane Street first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Jane Street's Sierra Oncology, Inc. Common Stock position peaked at $4.17M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.